Literature DB >> 34272989

The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.

Valentina Garibotto1,2, Nathalie L Albert3, Henryk Barthel4, Bart van Berckel5, Ronald Boellaard5, Matthias Brendel3,6,7, Diego Cecchin8, Ozgul Ekmekcioglu9, Elsmarieke van de Giessen5, Eric Guedj10, Adriaan A Lammerstma5,11, Franck Semah12, Tatjana Traub-Weidinger13, Donatienne Van Weehaeghe14, Silvia Morbelli15.   

Abstract

Entities:  

Year:  2021        PMID: 34272989     DOI: 10.1007/s00259-021-05485-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  24 in total

1.  Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic.

Authors:  Flora H Duits; Niels D Prins; Afina W Lemstra; Yolande A L Pijnenburg; Femke H Bouwman; Charlotte E Teunissen; Philip Scheltens; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2014-08-22       Impact factor: 21.566

2.  Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics.

Authors:  Valentina Garibotto; Marina Boccardi; Arturo Chiti; Giovanni B Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07       Impact factor: 9.236

Review 3.  Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.

Authors:  Sanna-Kaisa Herukka; Anja Hviid Simonsen; Niels Andreasen; Ines Baldeiras; Maria Bjerke; Kaj Blennow; Sebastiaan Engelborghs; Giovanni B Frisoni; Tomasz Gabryelewicz; Samantha Galluzzi; Ron Handels; Milica G Kramberger; Agnieszka Kulczyńska; Jose Luis Molinuevo; Barbara Mroczko; Agneta Nordberg; Catarina Resende Oliveira; Markus Otto; Juha O Rinne; Uroš Rot; Esen Saka; Hilkka Soininen; Hanne Struyfs; Silvia Suardi; Pieter Jelle Visser; Bengt Winblad; Henrik Zetterberg; Gunhild Waldemar
Journal:  Alzheimers Dement       Date:  2016-10-27       Impact factor: 21.566

Review 4.  The role of positron emission tomography imaging in understanding Alzheimer's disease.

Authors:  Henryk Barthel; John Seibyl; Osama Sabri
Journal:  Expert Rev Neurother       Date:  2015-03-09       Impact factor: 4.618

5.  Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease.

Authors:  Matteo Cotta Ramusino; Valentina Garibotto; Ruggero Bacchin; Daniele Altomare; Alessandra Dodich; Frederic Assal; Aline Mendes; Alfredo Costa; Michele Tinazzi; Silvia D Morbelli; Matteo Bauckneht; Agnese Picco; Massimo E Dottorini; Cristina Tranfaglia; Lucia Farotti; Nicola Salvadori; Davide Moretti; Giordano Savelli; Anna Tarallo; Flavio Nobili; Maura Parapini; Carlo Cavaliere; Elena Salvatore; Marco Salvatore; Marina Boccardi; Giovanni B Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-06       Impact factor: 9.236

Review 6.  The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.

Authors:  N J Ashton; A Leuzy; T K Karikari; N Mattsson-Carlgren; A Dodich; M Boccardi; J Corre; A Drzezga; A Nordberg; R Ossenkoppele; H Zetterberg; K Blennow; G B Frisoni; V Garibotto; O Hansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-06       Impact factor: 9.236

7.  ENGAGE and EMERGE: Truth and consequences?

Authors:  Lewis H Kuller; Oscar L Lopez
Journal:  Alzheimers Dement       Date:  2021-03-03       Impact factor: 21.566

8.  Atraumatic versus traumatic lumbar puncture needles: a systematic review and meta-analysis protocol.

Authors:  Siddharth Nath; Jetan H Badhiwala; Waleed Alhazzani; Farshad Nassiri; Emilie Belley-Cote; Alex Koziarz; Ashkan Shoamanesh; Laura Banfield; Wieslaw Oczkowski; Mike Sharma; Demetrios Sahlas; Kesava Reddy; Forough Farrokhyar; Sheila Singh; Sunjay Sharma; Nicole Zytaruk; Magdy Selim; Saleh A Almenawer
Journal:  BMJ Open       Date:  2017-03-31       Impact factor: 2.692

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

10.  Association of amyloid-β CSF/PET discordance and tau load 5 years later.

Authors:  Juhan Reimand; Lyduine Collij; Philip Scheltens; Femke Bouwman; Rik Ossenkoppele
Journal:  Neurology       Date:  2020-09-10       Impact factor: 9.910

View more
  1 in total

1.  A comparison of advanced semi-quantitative amyloid PET analysis methods.

Authors:  Enrico Peira; Davide Poggiali; Matteo Pardini; Henryk Barthel; Osama Sabri; Silvia Morbelli; Annachiara Cagnin; Andrea Chincarini; Diego Cecchin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-02       Impact factor: 10.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.